Affiliation:
1. Instituto Nacional de Cancerología (Mexico’s National Cancer Institute), San Fernando 22, Tlalpan, Mexico City 14080, Mexico
2. Hospital General de Tula, Carretera Tula-Tepeji Km 1.5, El Carmen, Tula de Allende 42830, Mexico
Abstract
Introduction: The current state of pathology practice and the variability in diagnosing pT4a colon cancer have been underexplored in existing studies. Our objective was to establish a specific cutoff point to distinguish between the pathological stages of pT3 and pT4a in colon cancer. Methods: We conducted a cross-sectional study involving pT3 and pT4 (pN0-2, cM0) colon cancers, measuring the distance to the serosa. Patients were categorized and analyzed based on this distance and the peritoneal reaction, with the aim being to ascertain their prognostic implications. Results: A total of 384 patients were analyzed. Patients with a distance between the invading front of cancer and the serosa ≥ 1 mm without a peritoneal reaction exhibited a median survival of 118 months, contrasting the amount of 70 months for those with <1 mm plus peritoneal reaction. Only lengths <1 mm with peritoneal reaction showed a significant correlation with mortality (p < 0.001). Conclusion: Our study revealed that patients in whom neoplastic cells were less than 1 mm from the serosal surface, accompanied by a peritoneal reaction (hemorrhage, inflammation, neovascularization, fibrin), had significantly lower survival rates compared to those with more than 1 mm distance and without peritoneal response (70 vs. 118 months, p < 0.001). Hence, such cases should be considered within the pT4a stage.
Reference29 articles.
1. (2023, May 08). World Gastroenterology Organization/International Digestive Cancer Alliance Practice Guidelines: Colorectal Cancer Screening. Available online: http://www.worldgastroenterology.org/assets/downloads/es/pdf/guidelines/cancer_colorectal_tamizaje_screening_y_vigilancia.
2. Cancer statistics, 2023;Siegel;CA Cancer J Clin.,2023
3. Colorectal cancer: Epidemiology, risk factors, and health services;Amersi;Clin. Colon Rectal Surg.,2005
4. Locally advanced colon cancer; current clinical practice and treatment outcome in the Netherlands;Klaver;Color. Dis.,2015
5. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer;Thomassen;Eur. J. Surg. Oncol.,2014